[Neurocysticercosis and convulsive crises].
Fernández-Gómez
J M
JM
García-Garmendia
J L
JL
López-Domínguez
J M
JM
Casado-Chocán
J L
JL
D000328:Adult; D015766:Albendazole / Q000627:therapeutic use; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D000909:Antibodies, Helminth / Q000097:blood; D000927:Anticonvulsants / Q000627:therapeutic use; D002114:Calcinosis / Q000000981:diagnostic imaging / Q000469:parasitology; D003551:Cysticercosis / Q000150:complications* / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D004484:Ecuador / Q000208:ethnology; D004660:Encephalitis / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000469:parasitology; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy / Q000209:etiology* / Q000469:parasitology; D006801:Humans; D008297:Male; D010672:Phenytoin / Q000627:therapeutic use; D013030:Spain; D013621:Taenia / Q000276:immunology; D014057:Tomography, X-Ray Computed
D000871:Anthelmintics; D000909:Antibodies, Helminth; D000927:Anticonvulsants; D010672:Phenytoin; D015766:Albendazole
Neurocisticercosis y crisis convulsivas.